Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Martina Vašáková (Praha, Czech Republic), Martina Vašáková, Martina Sterclova, Jan Kus, Vladimir Bartos, Marta Hajkova, Martina Doubkova, Veronika Muller, Martina Plackova, Monika Zurkova, Vladimira Lostakova, Ladislav Lacina, Vladimir Rihak, Frantisek Petrik, Pavlina Lisá, Radka Bittenglova, Dragana Jovanovic, Richard Tyl, Gustav Ondrejka, Hana Suldova, Jaroslav Lnenicka, Jana Psikalova, Tomas Snizek, Jiri Homolka, Renata Kralova, Jan Kervitzer, Michal Svoboda, Jana Strenkova. Does early diagnosis of idiopathic pulmonary fibrosis matter? Real- world´s data from the EMPIRE registry. Eur Respir J 2016; 48: Suppl. 60, 794

Member's Comments

No comment yet.

Related content which might interest you: Clinical outcomes of patients with idiopathic pulmonary fibrosis in clinical practice: Follow-up results of the INSIGHTS-IPF registry Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 Real world idiopathic pulmonary fibrosis in the EMPIRE registry Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries Year: 2018 Real life experience with nintedanib in patients with idiopathic pulmonary fibrosis Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Onset of symptoms in idiopathic pulmonary fibrosis: A case-control study Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 A global registry for idiopathic pulmonary fibrosis: the time is now Source: Eur Respir J 2014; 44: 273-276 Year: 2014 Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry Source: Eur Respir J 2015; 46: 186-196 Year: 2015 Pirfenidone in idiopathic pulmonary fibrosis - Real life experience from a german tertiary referral centre for interstitial lung diseases Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Idiopathic pulmonary fibrosis (IPF) patients in Poland – preliminary cohort analysis of EMPIRE registry Source: International Congress 2017 – ILDs: clinical aspects Year: 2017 Considerations of a warm autopsy program for patients with idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010 The epidemiologic features and the patterns of medical resource use in idiopathic pulmonary fibrosis (IPF) in Korea Source: International Congress 2015 – IPF: clinical aspects Year: 2015 Validation of GAP score in Danish patients diagnosed with idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Clinical course and changes in high-resolution computed tomography findings in patients with idiopathic pulmonary fibrosis without honeycombing Source: International Congress 2015 – New insights into IIPs Year: 2015 Clinical characteristics of patients with Idiopathic pulmonary fibrosis in a tertiary care center of a developing country Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Clinical characteristics and survival in patients with idiopathic pulmonary fibrosis with and without associated emphysema Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view Year: 2013 Approach to diagnosis of idiopathic pulmonary fibrosis Source: International Congress 2016 – Russia Session Year: 2016 Predictors of response to pirfenidone treatment in patients with idiopathic pulmonary fibrosis (IPF) Source: International Congress 2016 – IPF treatment II Year: 2016 Accuracy of “pulmonary fibrosis” diagnosis on death certificates – All scarring isn’t IPF Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Who and what should we rely on in early diagnosis of idiopathic pulmonary fibrosis? Source: Eur Respir J 2013; 41: 249-250 Year: 2013 Who and what should we rely on in early diagnosis of idiopathic pulmonary fibrosis? Source: Eur Respir J 2013; 41: 250-251 Year: 2013 Inspiration plus: baseline characteristics of the canadian registry for IPF patients on pirfenidone Source: International Congress 2016 – Orphan diseases II Year: 2016